| Marco M Zahedi M D A Medical Corporation | |
|
1200 N Tustin Ave Ste 120 Santa Ana CA 92705-6502 | |
| (949) 371-9862 | |
| (866) 439-4879 |
| Full Name | Marco M Zahedi M D A Medical Corporation |
|---|---|
| Speciality | General Practice |
| Location | 1200 N Tustin Ave Ste 120, Santa Ana, California |
| Authorized Official Name and Position | Marco M Zahedi (MEDICAL DIRECTOR) |
| Authorized Official Contact | 9493719862 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Marco M Zahedi M D A Medical Corporation 3972 Barranca Pkwy Suite J #490 Irvine CA 92606-1204 Ph: (949) 371-9862 | Marco M Zahedi M D A Medical Corporation 1200 N Tustin Ave Ste 120 Santa Ana CA 92705-6502 Ph: (949) 371-9862 |
| NPI Number | 1013454495 |
|---|---|
| Provider Enumeration Date | 01/24/2017 |
| Last Update Date | 07/21/2022 |
| Medicare PECOS PAC ID | 5991072753 |
|---|---|
| Medicare Enrollment ID | O20170525002554 |
News Archive
A paper published in the current issue of psychotherapy and psychosomatics provides data concerned with the appropriateness of a diagnosis of post-traumatic stress disorder in women with a diagnosis of cancer.
Cipher Pharmaceuticals Inc. today announced that it has reached the enrollment mid-point in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. To date, more than 400 patients have been enrolled. Achieving this milestone triggers a US$2.0 million milestone payment from Ranbaxy Pharmaceuticals Inc., Cipher's U.S. marketing and distribution partner.
Your microbiota may not be on your side as you try improving your diet this New Year's. In a study published December 29 in Cell Host & Microbe, researchers explore why mice that switch from an unrestricted American diet to a healthy, calorie-restricted, plant-based diet don't have an immediate response to their new program.
New research conducted by neuroscientists from the Royal College of Surgeons in Ireland (RCSI) published in Nature Medicine has identified a new gene involved in epilepsy and could potentially provide a new treatment option for patients with epilepsy.
A team from University of Newcastle upon Tyne in the UK have found that the anti-cancer drug Trichostatin A (TSA), has the potential to control early labour contractions. They are optimistic the work, which is still in the early stages, will help to reduce the 70,000 premature births in the UK each year.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013454495 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | A138224 (California) | Primary |
| Provider Name | Marco Zahedi |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1063779163 PECOS PAC ID: 0749590156 Enrollment ID: I20151113001020 |
News Archive
A paper published in the current issue of psychotherapy and psychosomatics provides data concerned with the appropriateness of a diagnosis of post-traumatic stress disorder in women with a diagnosis of cancer.
Cipher Pharmaceuticals Inc. today announced that it has reached the enrollment mid-point in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. To date, more than 400 patients have been enrolled. Achieving this milestone triggers a US$2.0 million milestone payment from Ranbaxy Pharmaceuticals Inc., Cipher's U.S. marketing and distribution partner.
Your microbiota may not be on your side as you try improving your diet this New Year's. In a study published December 29 in Cell Host & Microbe, researchers explore why mice that switch from an unrestricted American diet to a healthy, calorie-restricted, plant-based diet don't have an immediate response to their new program.
New research conducted by neuroscientists from the Royal College of Surgeons in Ireland (RCSI) published in Nature Medicine has identified a new gene involved in epilepsy and could potentially provide a new treatment option for patients with epilepsy.
A team from University of Newcastle upon Tyne in the UK have found that the anti-cancer drug Trichostatin A (TSA), has the potential to control early labour contractions. They are optimistic the work, which is still in the early stages, will help to reduce the 70,000 premature births in the UK each year.
› Verified 2 days ago
News Archive
A paper published in the current issue of psychotherapy and psychosomatics provides data concerned with the appropriateness of a diagnosis of post-traumatic stress disorder in women with a diagnosis of cancer.
Cipher Pharmaceuticals Inc. today announced that it has reached the enrollment mid-point in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. To date, more than 400 patients have been enrolled. Achieving this milestone triggers a US$2.0 million milestone payment from Ranbaxy Pharmaceuticals Inc., Cipher's U.S. marketing and distribution partner.
Your microbiota may not be on your side as you try improving your diet this New Year's. In a study published December 29 in Cell Host & Microbe, researchers explore why mice that switch from an unrestricted American diet to a healthy, calorie-restricted, plant-based diet don't have an immediate response to their new program.
New research conducted by neuroscientists from the Royal College of Surgeons in Ireland (RCSI) published in Nature Medicine has identified a new gene involved in epilepsy and could potentially provide a new treatment option for patients with epilepsy.
A team from University of Newcastle upon Tyne in the UK have found that the anti-cancer drug Trichostatin A (TSA), has the potential to control early labour contractions. They are optimistic the work, which is still in the early stages, will help to reduce the 70,000 premature births in the UK each year.
› Verified 2 days ago
Hurtt Family Health Clinic, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1100b N Tustin Ave Ste Adf, Santa Ana, CA 92705 Phone: 714-247-4300 Fax: 714-259-1598 | |
Chirohealthcare Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3701 W Mcfadden Ave Ste E, Santa Ana, CA 92704 Phone: 714-531-8478 Fax: 714-531-8475 | |
Birthchoice Health Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 415 N Sycamore St, St. 200, Santa Ana, CA 92701 Phone: 714-836-5447 Fax: 714-836-1855 | |
Celebrating Life Community Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1444 S Main St, Santa Ana, CA 92707 Phone: 949-866-3600 | |
Children's Hospital Of Orange County Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 406 S Main St, Santa Ana, CA 92701 Phone: 714-289-4800 | |
Hca-phs-family Health Clinic-dental Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1725 W 17th St, Ste # 101l, Santa Ana, CA 92706 Phone: 714-567-6214 Fax: 714-834-8361 |